In summary, we identified MCM2 and NUSAP1 as potential biomarkers for the diagnosis and prognosis of PC using analysis of genetic variation, verification of differential expression, and evaluation of the survival, prognostic, and diagnostic value of the 20 hub genes. The gene discussed is MCM2; the disease is pachyonychia congenita.